Enhance your nephrology practice with CME and tools focused on kidney medicine.
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Ellie Kelepouris, MD, FACP, FAHA
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
Nihar R. Desai, MD, MPH
Pauline A. Swift, PhD
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Peter Rossing, MD, DMSc
Real-World Evidence: Effectiveness of Finerenone in Reducing UACR in Patients With CKD and Type 2 Diabetes
Csaba P. Kovesdy, MD
The Evolving Role of Biomarkers in IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Decoding IgA Nephropathy: From Suspicion to Solution
An De Vriese, MD, PhD
Jörg Latus, MD
Navigating KDIGO Guidance in IgAN
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Unmasking IgAN: Achieving Earlier Diagnosis
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Potassium Binders to Optimize GDMT Therapy in HFrEF
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Gabapentinoids: Safety Considerations and Downstream Outcomes
Reading Between the Lines: What PROMs Reveal About Itch
What You Don’t See: A Patient’s View of Living with CKD-aP
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.